Literature DB >> 26087539

[Siwu series decoctions for treating primary dysmenorrea of gynecology blood stasis syndrome--research progress of Taohong Siwu decoction].

Li Liu, Jin-ao Duan, Shu-lan Su, Pei Liu, Yu-ping Tang, Da-wei Qian.   

Abstract

The relevant literatures of Siwu series decoctions--Taohong Siwu decoction for treating primary dysmenorrea of gynecology blood stasis syndrome were summarized including the clinical application, pharmacological effects, bioactive components and metabolic characteristics. On this basis,research on the bioactive components and formulation rule were discussed, to provide reference for modern traditional Chinese medicine formula study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26087539

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Integrated Modules Analysis to Explore the Molecular Mechanisms of Phlegm-Stasis Cementation Syndrome with Ischemic Heart Disease.

Authors:  Wei-Ming Xu; Kuo Yang; Li-Jie Jiang; Jing-Qing Hu; Xue-Zhong Zhou
Journal:  Front Physiol       Date:  2018-01-22       Impact factor: 4.566

2.  UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment.

Authors:  Xianchun Duan; Lingyu Pan; Qiuyu Bao; Daiyin Peng
Journal:  Front Pharmacol       Date:  2020-01-24       Impact factor: 5.810

3.  Systematic Pharmacology-Based Strategy to Explore the Molecular Network Mechanism of Modified Taohong Siwu Decoction in the Treatment of Premature Ovarian Failure.

Authors:  Xiao Yuan; Wang Xiang; Kailin Yang; Huiping Liu; Guomin Zhang; Qi He; Jiapeng Fan
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-21       Impact factor: 2.629

4.  Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental Verification.

Authors:  Shi Huang; Yan Chen; Lingyu Pan; Changyi Fei; Ni Wang; Furui Chu; Daiyin Peng; Xianchun Duan; Yongzhong Wang
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.